Screening of traditional Chinese medicine monomers as ribonucleotide reductase M2 inhibitors for tumor treatment

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 10, Issue 31

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Clinical Cases

ISSN

2307-8960

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Clinical and Translational Research

World J Clin Cases. Nov 6, 2022; 10(31): 11299-11312
Published online Nov 6, 2022. doi: 10.12998/wjcc.v10.i31.11299

Table 1 Tumor abbreviations

Abbreviation	Full name	Abbreviation	Full name	Abbreviation	Full name
ACC	Adrenocortical carcinoma	BLCA	Bladder Urothelial Carcinoma	BRCA	Breast invasive carcinoma
CESC	Cervical squamous cell carcinoma and endocervical adenocarcinoma	CHOL	Cholangio carcinoma	COAD	Colon adenocarcinoma
DLBC	Lymphoid Neoplasm Diffuse Large B-cell Lymphoma	ESCA	Esophageal carcinoma	GBM	Glioblastoma multiforme
HNSC	Head and Neck squamous cell carcinoma	KICH	Kidney Chromophobe	KIRC	Kidney renal clear cell carcinoma
KIRP	Kidney renal papillary cell carcinoma	LAML	Acute Myeloid Leukemia	LGG	Brain Lower Grade Glioma
LIHC	Liver hepatocellular carcinoma	LUAD	Lung adenocarcinoma	LUSC	Lung squamous cell carcinoma
MESO	Mesothelioma	OV	Ovarian serous cystadenocarcinoma	PAAD	Pancreatic adenocarcinoma
PCPG	Pheochromocytoma and Paraganglioma	PRAD	Prostate adenocarcinoma	READ	Rectum adenocarcinoma
SARC	Sarcoma	SKCM	Skin Cutaneous Melanoma	STAD	Stomach adenocarcinoma
UCEC	Uterine Corpus Endometrial Carcinoma	UCS	Uterine Carcinosarcoma	UVM	Uveal Melanoma
TGCT	Testicular Germ Cell Tumors	THCA	Thyroid carcinoma	THYM	Thymoma

Citation: Qin YY, Feng S, Zhang XD, Peng B. Screening of traditional Chinese medicine monomers as ribonucleotide reductase M2 inhibitors for tumor treatment. World J Clin Cases 2022; 10(31): 11299-11312
URL: https://www.wjgnet.com/2307-8960/full/v10/i31/11299.htm
DOI: https://dx.doi.org/10.12998/wjcc.v10.i31.11299

Qin YY, Feng S, Zhang XD, Peng B. Screening of traditional Chinese medicine monomers as ribonucleotide reductase M2 inhibitors for tumor treatment. World J Clin Cases 2022; 10(31): 11299-11312 [PMID: 36387821 DOI: 10.12998/wjcc.v10.i31.11299]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.